KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT05294172 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05294172
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Recurrent or Metastatic

Start date: 2022-06-07
Primary completion: 2027-12-01
Enrollment: 295

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.